The initial success of Sildenafil undeniably revolutionized the drug landscape, but placing funds in companies primarily reliant on generic versions presents a uncertain picture. Although early returns were substantial, the end of patents and the emergence of discounted alternatives have diminished market share. Therefore, a thorough analysis of… Read More